BC
Boxer Capital Portfolio holdings
AUM
$2.04B
This Quarter Return
+52.32%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$424M
AUM Growth
+$424M
(+79%)
Cap. Flow
+$98M
Cap. Flow
% of AUM
23.11%
Top 10 Holdings %
Top 10 Hldgs %
85.77%
Holding
33
New
6
Increased
5
Reduced
2
Closed
3
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$45M |
| 2 |
MDCO
Medicines Co
MDCO
|
$18.9M |
| 3 |
PTC Therapeutics
PTCT
|
$14.8M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$9.55M |
| 5 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$5M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$4.71M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$1.76M |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$663K |
| 4 |
AKTX
Akari Therapeutics
AKTX
|
$497K |
| 5 |
ARDM
Aradigm Corp Common Stock
ARDM
|
$90.7K |
Sector Composition
| 1 | Healthcare | 85.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKTX
26
Akari Therapeutics
AKTX
$24.8M
| $1.05M | 0.23% | 95,011 -44,888 | -32% | -$497K |
|
27
Traws Pharma
TRAW
$9.89M
| $962K | 0.21% | 316,386 +6 | +0% | +$18 |
|
|
ARDM
28
DELISTED
Aradigm Corp Common Stock
ARDM
| $893K | 0.2% | 576,208 -58,500 | -9% | -$90.7K |
|
|
NVET
29
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| $602K | 0.13% | 154,840 | – | – |
|
|
ONTXW
30
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
| $202K | 0.04% | 241,644 | – | – |
|
|
ARRY
31
DELISTED
Array Biopharma Inc
ARRY
| – | – | -200,000 | Closed | -$1.76M |
|
|
TSRO
32
DELISTED
TESARO, Inc.
TSRO
| – | – | -35,000 | Closed | -$4.71M |
|
|
RXDX
33
DELISTED
Ignyta, Inc.
RXDX
| – | – | -125,000 | Closed | -$663K |
|